Development code · Small Molecule
JZP-110
JZP-110 is a development code for Solriamfetol (Sunosi), developed by Axsome Therapeutics, Inc..
- Status
- Phase 3 for Major depressive disorder
- Mechanism
- NET Reuptake inhibitor
- Developer
- Axsome Therapeutics, Inc.
Programs
- Solriamfetol (Sunosi) for Major depressive disorderPhase 3Recruiting
- Solriamfetol (Sunosi) for Attention-deficit/hyperactivity disorderPhase 3Active
- Solriamfetol (Sunosi) for Binge eating disorderPhase 3Recruiting
- Solriamfetol (Sunosi) for Excessive daytime sleepinessPhase 3Recruiting
Also known as
- ADX-N05
- ADXN05
- Sunosi
- solriamfetol
- 178429-62-4